Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice

Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice

From the perspective of epidemiology, viral immunology and current clinical research, pulmonary fibrosis may become one of the complications of patients with Coronavirus Disease 2019 (COVID-19). Cytokine storm is a major cause of new coronavirus death. The purpose of this study was to explore the ef...

Full description

Bibliographic Details
Main Authors: Hailong Li, Rui Liu, Ruotong Zhang, Shanshan Zhang, Yiying Wei, Liang Zhang, Honggang Zhou, Cheng Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Pharmacology
Subjects:
arbidol
COVID-19
pulmonary fibrosis
cytokine storm
sepsis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.607075/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.607075/full

Similar Items